Boston Scientific closes $1B public offering — 3 insights

On Feb. 26, Boston Scientific completed a $1 billion public offering of 4 percent interest rate senior notes due March 1, 2028.

Here's what you should know:

1. The proceeds of the offering will redeem the 2.65 percent notes that were due October 2016. Boston Scientific had approximately $600 million in aggregate principal outstanding on the notes as of Feb. 26.

2. The company needs to repay short-term debt and related fees, expenses and premiums.

3. Once paid, Boston Scientific will provide redemption notices to trustees.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast